​
Login / Signup
Christine de la Loge
ORCID
Publication Activity (10 Years)
Years Active: 2021-2023
Publications (10 Years): 4
Top Topics
Anti Inflammatory
Respiratory Syncytial Virus
Myasthenia Gravis
Top Venues
Neurology and therapy
Patient related outcome measures
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Antoine Regnault
,
Thomas Morel
,
Christine de la Loge
,
Flora Mazerolle
,
Henry J Kaminski
,
Thomas H Brannagan
Measuring Overall Severity of Myasthenia Gravis (MG): Evidence for the Added Value of the MG Symptoms PRO.
Neurology and therapy
(2023)
Antoine Regnault
,
Thomas Morel
,
Christine de la Loge
,
Flora Mazerolle
,
Henry J Kaminski
,
Thomas H Brannagan
Correction to: Measuring Overall Severity of Myasthenia Gravis (MG): Evidence for the Added Value of the MG Symptoms PRO.
Neurology and therapy
(2023)
Antoine Regnault
,
Thomas Morel
,
Christine de la Loge
,
Flora Mazerolle
,
Henry J Kaminski
,
Thomas H Brannagan
Correction to: Measuring Overall Severity of Myasthenia Gravis (MG): Evidence for the Added Value of the MG Symptoms PRO.
Neurology and therapy
(2023)
Christine de la Loge
,
Fatoumata Fofana
,
Paul Williams
,
Sarah Rusch
,
Marita Stevens
,
Jane Scott
Monitoring Severity of Respiratory Syncytial Virus (RSV) in Infants and Young Children Using the Pediatric RSV Electronic Severity and Outcome Rating System (PRESORS): Results of Initial Quantitative Validation.
Patient related outcome measures
12 (2021)